05 August, 2017
(NYSE:Q) by 1.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,155 shares of the medical research company's stock after selling 390 shares during the period.
More recent Quintiles IMS Holdings Inc (NYSE:Q) news were published by: Seekingalpha.com which released: "Quintiles IMS: A Novel Way To Invest In Biopharma" on July 17, 2017. Magnetar Fincl Ltd Llc has 0.01% invested in Quintiles IMS Holdings Inc (NYSE:Q). Oppenheimer & Co. Inc. now owns 11,231 shares of the medical research company's stock worth $904,000 after buying an additional 6,371 shares during the last quarter.
Quintiles Transitional Holdings Inc. had its " rating reiterated by analysts at Barclays. IFP Advisors Inc now owns 1,774 shares of the medical research company's stock valued at $143,000 after buying an additional 1,156 shares during the last quarter. Pensionfund Sabic purchased a new stake in Quintiles Transitional Holdings during the first quarter valued at $1,562,000. It also reduced its holding in Duke Energy Corp New (NYSE:DUK) by 15,557 shares in the quarter, leaving it with 121,500 shares, and cut its stake in Colgate Palmolive Co (NYSE:CL).
02/03/2017 - Quintiles Transitional Holdings Inc. was downgraded to " by analysts at Deutsche Bank. The institutional investor held 96,705 shares of the consumer durables company at the end of 2016Q4, valued at $5.74 million, down from 135,970 at the end of the previous reported quarter. Following the transaction, the director now directly owns 2,930 shares of the company's stock, valued at approximately $241,725. The correct version of this piece can be viewed at https://transcriptdaily.com/2017/08/01/dnb-asset-management-as-purchases-900-shares-of-quintiles-transitional-holdings-inc-q-updated-updated-updated.html. (NYSE:Q) shares ended at $91.29 with 1.04 mln shares exchanging hands. The company has market cap of $19.64 billion. The firm's 50-day moving average price is $89.50 and its 200-day moving average price is $82.85. California State Teachers Retirement Sys invested 0.05% in Quintiles IMS Holdings Inc (NYSE:Q). Nuveen Asset Mngmt Ltd Company reported 213,889 shares. The medical research company reported $1.09 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.05 by $0.04. Analysts expect next quarter's EPS will be $1.33 with next year's EPS projected to be $5.25. Quintiles Transitional Holdings had a return on equity of 18.03% and a net margin of 1.06%. Quintiles Transitional Holdings's revenue was up 72.5% on a year-over-year basis. During the same quarter a year ago, the company earned $0.93 EPS. On average, equities research analysts predict that Quintiles Transitional Holdings Inc. will post $4.54 earnings per share for the current fiscal year.
Quintiles Transitional Holdings (NYSE:Q) last posted its earnings results on Wednesday, May 3rd. Fjarde Ap-Fonden Fourth Swedish National Pension Fund bought 11,592 shares as the company's stock rose 8.21% with the market. Stocks repurchase plans are often a sign that the firms board of directors believes its shares is undervalued.
TRADEMARK VIOLATION WARNING: This news story was posted by Rincon Hill News and is the sole property of of Rincon Hill News. If you are viewing this story on another site, it was stolen and reposted in violation of United States and worldwide copyright & trademark law. It is positive, as 39 investors sold Q shares while 93 reduced holdings. Credit Suisse Group assumed coverage on Quintiles Transitional Holdings in a research note on Friday, March 31st.
Shares of Quintiles Transitional Holdings Inc. Mizuho raised their target price on Quintiles Transitional Holdings from $90.00 to $93.00 and gave the company a "buy" rating in a research report on Thursday, May 4th. Evercore ISI restated an "in-line" rating and set a $88.50 target price (up previously from $84.00) on shares of Quintiles Transitional Holdings in a research report on Thursday, May 4th. Eleven analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. The corporation has a consensus rating of "Hold" and an consensus price target of $88.22. The shares were sold at an average price of $82.50, for a total value of $502,590.00. Also, Director Dennis B. Ph D. Gillings sold 860,000 shares of the business's stock in a transaction that occurred on Wednesday, May 31st. The average 1-year price target for (Q) reveals an average price target of $93.59 per share. The disclosure for this sale can be found here. Following the completion of the transaction, the director now directly owns 10,002,230 shares in the company, valued at $840,287,342.30.
Quintiles IMS Holdings Inc (NYSE:Q) has risen 27.93% since August 2, 2016 and is uptrending. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services.
